Tuberculosis treatment monitoring and outcome measures: new interest and new strategies

J Heyckendorf, SB Georghiou, N Frahm… - Clinical microbiology …, 2022 - Am Soc Microbiol
Despite the advent of new diagnostics, drugs and regimens, tuberculosis (TB) remains a
global public health threat. A significant challenge for TB control efforts has been the …

18F-FDG PET/CT in Infective Endocarditis: Indications and Approaches for Standardization

D Ten Hove, R Slart, B Sinha, A Glaudemans… - Current cardiology …, 2021 - Springer
Abstract Purpose of Review Additional imaging modalities, such as FDG-PET/CT, have been
included into the workup for patients with suspected infective endocarditis, according to …

Doxycycline host-directed therapy in human pulmonary tuberculosis

QH Miow, AF Vallejo, Y Wang, JM Hong… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND Matrix metalloproteinases (MMPs) are key regulators of tissue destruction in
tuberculosis (TB) and may be targets for host-directed therapy. We conducted a phase II …

FDG-PET/CT of COVID-19 and other lung infections

LS Eibschutz, B Rabiee, S Asadollahi, A Gupta… - Seminars in nuclear …, 2022 - Elsevier
While not conventionally used as the first-line modality,[18 F]-2-fluoro-2-deoxy-D-glucose
(FDG)-positron emission tomography/computed tomography (PET/CT) can identify infection …

Molecular imaging of innate immunity and immunotherapy

W Xia, N Singh, S Goel, S Shi - Advanced Drug Delivery Reviews, 2023 - Elsevier
The innate immune system plays a key role as the first line of defense in various human
diseases including cancer, cardiovascular and inflammatory diseases. In contrast to tissue …

[HTML][HTML] Spatiotemporal perspectives on tuberculosis chemotherapy

J Zhu, YJ Liu, SM Fortune - Current opinion in microbiology, 2023 - Elsevier
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), accounts for
over ten million infections and over 1.5 million deaths every year [1]. Upon infection, the …

Does PET-CT have a role in the evaluation of tuberculosis treatment in phase 2 clinical trials?

GB Cross, J O'Doherty, CC Chang… - The Journal of …, 2024 - academic.oup.com
Positron emission tomography–computed tomography (PET-CT) has the potential to
revolutionize research in infectious diseases, as it has done with cancer. There is growing …

Visualizing the dynamics of tuberculosis pathology using molecular imaging

AA Ordonez, EW Tucker, CJ Anderson… - The Journal of …, 2021 - Am Soc Clin Investig
Nearly 140 years after Robert Koch discovered Mycobacterium tuberculosis, tuberculosis
(TB) remains a global threat and a deadly human pathogen. M. tuberculosis is notable for …

[HTML][HTML] Deep learning and radiomics of longitudinal CT scans for early prediction of tuberculosis treatment outcomes

M Nijiati, L Guo, A Abulizi, S Fan, A Wubuli… - European Journal of …, 2023 - Elsevier
Background To predict tuberculosis (TB) treatment outcomes at an early stage, prevent poor
outcomes of drug-resistant tuberculosis (DR-TB) and interrupt transmission. Methods An …

PET-CT outcomes from a randomised controlled trial of rosuvastatin as an adjunct to standard tuberculosis treatment

GB Cross, IP Sari, SM Burkill, CW Yap… - Nature …, 2024 - nature.com
Adjunctive rosuvastatin for rifampicin-susceptible pulmonary tuberculosis (rs-PTB) shows no
effect on microbiological or radiological outcomes in a phase IIb randomised, controlled trial …